Arun Agarwal, the founder and CEO of Janitri, grew up in Alwar, Rajasthan, witnessing preventable maternal and newborn deaths in his local community. Driven to find a solution, he founded Janitri in 2016 after visiting over 100 hospitals and primary health centers to identify critical fetal and maternal monitoring gaps. Today, Janitri monitors over 200,000 pregnancies per month across more than 800 hospitals in 11 countries. The startup has saved over 8,000 lives, raised $3.98 million in total funding, holds a ₹99.2 crore valuation, and was selected for the prestigious VivaTech 2026 conference in France.
Alwar, a Grandfather's Business, Biomedical Engineering, and 100 Hospital Visits That Revealed Everything
Arun Agarwal grew up in Alwar, Rajasthan, within a family environment where his grandfather ran a traditional wood-trading business. This early exposure taught him foundational lessons about value creation, market demand, and inventory management. While technology captivated him from childhood, it was the preventable maternal deaths he witnessed in his immediate community that gave his engineering ambitions a clear, human purpose.
He pursued a B.Tech in Electronics and followed it with an M.Tech in Biomedical Engineering at the Vellore Institute of Technology (VIT). His deep involvement in robotics clubs and national tech festivals confirmed both his advanced technical capability and his natural entrepreneurial instinct.
After a brief stint working as a corporate patent analyst, Arun began spending his spare time visiting healthcare facilities across both rural and urban India. Over a hundred centers later, a troubling pattern emerged everywhere he looked: most primary health centers lacked affordable, reliable tools for fetal and maternal monitoring. Local nurses and doctors were operating without adequate data, often missing early, critical signs of distress during pregnancy and active labor.
"Technology will be playing a critical role during pregnancy, labour and newborn vitals monitoring for early decision making and ultimately help in reducing MMR [Maternal Mortality Ratio] and IMR [Infant Mortality Rate]," Arun explains.
In 2016, supported by the Biotechnology Industry Research Assistance Council's (BIRAC) SIIP Fellowship, he officially founded Janitri Innovations in Bengaluru.
Keyar Patch, Daksh App, AI Monitoring, and Products That Give Every Nurse a Superpower
The founding product insight at Janitri was both technically sophisticated and operationally precise: the primary bottleneck in India's maternal healthcare system was not a shortage of skilled doctors, but a severe shortage of continuous, reliable monitoring data at the exact moment when it mattered most.
Arun's first major product invention, the Keyar Patch, is a non-invasive, wearable patch capable of tracking fetal heart rate, maternal pulse, and uterine contractions. The device sends data in real time to a connected application, allowing healthcare workers in lower-resourced clinics to monitor pregnancies with institutional accuracy.
Complementing the hardware is Daksh, a mobile application that digitizes labor monitoring by generating automated, WHO-guided digital partographs and instantly alerting caregivers to physiological abnormalities in real time.
The product portfolio has since expanded into a comprehensive ecosystem:
Maternal and fetal vitals monitoring devices
Complete labor monitoring software
A handheld fetal doppler
Keyar DT Lite for remote monitoring of high-risk pregnancies
A smart obstetric shock index monitor measuring heart rate, blood pressure, SpO2, and obstetric shock index to detect postpartum hemorrhage risks early
Newborn vitals monitoring devices
Advanced AI and ML algorithms analyze this continuous data stream to predict and prevent complications before they escalate into emergencies. With 12 patents filed and four already officially granted, Janitri's technology moat is as significant as its humanitarian impact. The company has trained over 1,500 healthcare professionals and generated over 25,000 alerts that enabled timely medical interventions.
Following Janitri's appearance on Shark Tank India Season 2, Emcure Pharmaceuticals Executive Director Namita Thapar invested ₹1 crore for 2.5% equity. She described her investment as a heartfelt commitment:
"From monitoring 1 lakh-plus mothers and saving 8,000-plus lives, Janitri is a testament to the power of making a social impact."
Post-Shark Tank visibility, Janitri's monthly sales jumped from ₹10 lakh to ₹50 lakh within a matter of months.
The 2025–2026 Chapter: Ashish Kacholia, Assam Government Deployment, and VivaTech France
In June 2025, Janitri raised $1.4 million in a pre-Series A funding round led by ace stock market investor Ashish Kacholia, who doubled down on the company after participating in a previous round. Other prominent participants included Prateek Maheshwari, Pradip Todi via O2 Angels, and the tal64 syndicate.
"Arun has spent time and effort in understanding unmet customer needs in the 1,000-days journey of maternal care," Ashish Kacholia stated. "Janitri's product is compact, full function, and enables cost-effective monitoring of mother and newborn for both hospital and home segment."
On February 1, 2026, the State Government of Assam marked a major milestone in its public healthcare journey by officially deploying Janitri's technology across its healthcare network, confirming government-level trust in the platform at state scale.
Furthermore, in 2026, Janitri was selected as part of the India Startup Delegation and Bharat Innovates 2026 initiative at VivaTech 2026 in France—Europe's largest startup and tech event—taking India's most impactful maternal health technology to the global stage.
The fresh capital is currently being deployed to expand sales and service networks, develop home-use pregnancy wearables, and introduce advanced neonatal monitoring tools for high-risk newborns. Arun envisions Janitri playing a critical role in the first 1,000 days of life, from conception to early infancy, through a suite of accessible, technology-enabled solutions.
Scale and Real-World Impact
Every metric below represents the verified growth, corporate performance, and real-world footprint of Janitri as it expands across the global healthcare landscape.
| Operational & Financial Metrics | Verified Performance Values |
| Headquarters & Launch Year | Bengaluru; Founded in 2016 |
| Audited FY25 Revenue | ₹5.14 Crore (As of March 31, 2025 per Tracxn) |
| Cumulative Revenue | Crossed ₹8.5 Crore by mid-2025, representing greater than 2x YoY growth |
| Current Corporate Valuation | ₹99.2 Crore |
| Founder Shareholding Value | Arun Agarwal's equity stake is valued at ₹50 Crore |
| Total Institutional Funding | $3.98 Million raised across 12 funding rounds |
| Investor Base | Supported by 26 institutional investors and 14 angel investors |
| Workforce Scale | 69 employees as of June 2025 (A 44% increase year-on-year) |
| Monthly Patient Velocity | Monitors over 200,000 pregnancies per month |
| Global Footprint | Active across 800-plus hospitals in India and 11 countries globally |
| Direct Humanitarian Impact | Over 8,000 lives saved; more than 25,000 critical alerts generated |
| Professional Training | Over 1,500 healthcare professionals trained on the ecosystem |
| Category Competitive Rank | Ranks 2nd among 10 active competitors in its medical device category |
| Domestic Market Potential | Estimated at a ₹2,000 Crore market opportunity in India alone |
| Indian MedTech Sector Value | Valued at $15 Billion today; projected to reach $30 Billion by 2030 |
The Business Lesson — The Most Powerful MedTech Companies Are the Ones That Solve the Problem the System Has Learned to Ignore
The sharpest lesson from Janitri's journey is this: the most transformative healthcare companies are built by founders who personally witnessed the problem, personally validated it across a hundred physical data points, and then built the most precise possible solution rather than focusing solely on the easiest way to scale.
Arun visited over 100 hospitals before he finalized a single product design. He understood not just what the market technically needed, but why the existing medical system had slowly learned to live without it. By applying that insight, he built a wearable patch that gives every local nurse in every primary health center the real-time monitoring capabilities of an institutional, high-tech labor ward.
"Each time I hear a story of how our device helped detect a complication early and enabled timely intervention, it gives me goosebumps," Arun says. "This is why we do what we do."
He grew up watching mothers die in Alwar. He visited 100 hospitals. He filed 12 patents. He saved 8,000 lives. He earned a ₹99.2 crore valuation. He is now heading to Europe's largest startup stage. And by every available metric, he is just getting started.
Sources: TAL64, Tracxn, Business Remedies, Business Standard, LinkedIn, HundrED Foundation, Crunchbase, BIRAC Records.
